What TherapeuticsMD Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 8,400 |
| Disposed | 0 | 0 |
| Net activity | +0 | +8,400 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Thompson Tommy G | Director | Dec 23 | Open-market buy · P | +8,400 | $1.67 | +$14K | 23,179 |
| Walker Marlan D | Chief Executive Officer | Apr 14 | Open-market buy · P | +490 | $1.00 | +$489 | 73,639 |
| Thompson Tommy G | Director | Apr 14 | Open-market buy · P | +325 | $1.00 | +$326 | 14,779 |
| Walker Marlan D | Chief Executive Officer | Apr 10 | Open-market buy · P | +1,167 | $0.86 | +$1K | 73,149 |
| Walker Marlan D | Chief Executive Officer | Apr 09 | Open-market buy · P | +1,136 | $0.87 | +$994 | 71,982 |
| Walker Marlan D | Chief Executive Officer | Feb 18 | Exercise / conversion · M | +1,733 | — | — | 70,846 |
| Walker Marlan D | Chief Executive Officer | Feb 18 | Exercise / conversion · M | +770 | — | — | 69,113 |
| Walker Marlan D | Chief Executive Officer | Feb 18 | Exercise / conversion · M | +2,311 | — | — | 68,343 |
| Walker Marlan D | Chief Executive Officer | Feb 18 | Exercise / conversion · M | +3,467 | — | — | 66,032 |
| Thompson Tommy G | Director | Feb 18 | Exercise / conversion · M | +8,500 | — | — | 14,454 |
| Naughton Gail K | Director | Feb 18 | Exercise / conversion · M | +8,500 | — | — | 8,500 |
| Collins Cooper C. | Director | Feb 18 | Exercise / conversion · M | +8,500 | — | — | 60,516 |
| Collins Cooper C. | Director | Aug 22 | Open-market buy · P | +4,094 | $1.73 | +$7.1K | 52,016 |
| Collins Cooper C. | Director | Aug 21 | Open-market buy · P | +1,200 | $1.70 | +$2.04K | 47,922 |
| Walker Marlan D | Chief Executive Officer | Dec 07 | Open-market sale · S | −4,550 | $2.24 | −$10.2K | 62,565 |
| Walker Marlan D | Chief Executive Officer | Dec 06 | Open-market sale · S | −14,500 | $2.31 | −$33.5K | 67,115 |
| Walker Marlan D | Chief Executive Officer | Dec 05 | Exercise / conversion · M | +70,000 | — | — | 81,615 |
| Rubric Capital Management Lp | Director | Nov 15 | Grant / award · A | +877,192 | $2.28 | +$2M | 2,946,908 |
| Ziegler Joseph | Principal Financial Officer | Aug 17 | Grant / award · A | +7,500 | — | — | 7,500 |
| Rubric Capital Management Lp | Director | Jun 28 | Grant / award · A | +312,525 | $3.68 | +$1.15M | 2,069,716 |
Loading...